NCT02880592View on ClinicalTrials.gov

Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

April 1, 2019

Study Completion Date

April 1, 2019

Conditions
Diabetic Foot Ulcers
Interventions
OTHER

Affinity Allograft

fresh hypothermically stored human amniotic membrane

OTHER

Standard of care

offloading, debridement, infection management using appropriate dressings

Trial Locations (8)

15222

SerenaGroup Research Institute, Pittsburgh

16201

Armstrong County Memorial Hospital, Kittanning

16226

The Foot and Ankle Wellness Center, Ford City

17201

Summit Health Hospital, Chambersburg

17402

Martin Foot and Ankle, York

33016

GF Professional Research, Miami Lakes

33169

Barry University Clinical Research, North Miami Beach

48038

Henry Ford Macomb Hospital, Clinton Township

Sponsors

Lead Sponsor

Organogenesis
All Listed Sponsors
collaborator

SerenaGroup, Inc.

NETWORK

lead

Organogenesis

INDUSTRY

NCT02880592 - Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter